Neoleukin Therapeutics Inc (NLTX): Neoleukin Therapeuti (NLTX) 7.69 ? 0.25...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	3156
Posts	963283
Boards Moderated	188
Alias Born	09/04/2000

mick

Re: None

Saturday, 11/06/2021 12:25:10 PM

Saturday, November 06, 2021 12:25:10 PM

Neoleukin Therapeuti (NLTX)
7.69 ? 0.25 (3.36%)
Volume: 172,375 @11/05/21 5:30:12 PM EDT
Bid Ask Day's Range
7.75 8.41 7.25 - 7.9
NLTX Detailed Quote

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent NLTX News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:15:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 11:31:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:31:58 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/21/2024 12:32:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 06:11:01 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 06:37:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 06:37:01 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 06:36:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 06:35:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 06:35:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:31:36 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:14:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 11:31:29 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 10:20:01 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 06:34:31 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 06:33:59 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/26/2024 06:33:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 08:44:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 07:43:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2024 08:10:58 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2024 08:04:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:54:55 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:53:21 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:51:43 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:29:25 PM

More NLTX News

InvestorsHub NewsWire

FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM

Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM

Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM

PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover